+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

T

Actively Recruiting

This research aims to evaluate whether cerebello-spinal direct current stimulation csDCS can improve walking ability and overall mobility in people who have chronic stroke-related gait disorders. The study also investigates the safety of this stimulation method by comparing its effects to a sham procedure, which mimics stimulation without actual impact. The trial is a phase 2 clinical study focused on stroke rehabilitation and functional mobility enhancement. Participants will receive either active csDCS or sham csDCS combined with treadmill training daily for two weeks. The csDCS device influences spinal pathways and reflex excitability to promote lasting neuroplastic changes. The sham procedure involves stopping the current after 30 seconds to create a sensation without neuromodulation. Both groups will undergo treadmill training alongside their assigned intervention. Participants will be assessed on their functional mobility before treatment, immediately after the two-week intervention, and again at a 30-day follow-up. Researchers will also measure independence level, lower limb motor function, balance, perceived changes from treatment, and spasticity at these same time points. The study uses a randomized, double-blind design to monitor outcomes and side effects during and after treatment, with total participation lasting about one month.

Age: 18Years - 75YearsAll GendersPhase 2
3 locations
E

Actively Recruiting

Researchers are studying whether trans-spinal magnetic stimulation can improve walking ability and functional mobility in adults who have chronic stroke-related gait disorders. The trial also aims to understand the safety of this stimulation technique by comparing it to a sham procedure that mimics the stimulation sounds but has no real effect. Participants will be randomly assigned to receive either active trans-spinal magnetic stimulation or sham stimulation, both combined with treadmill training. This treatment is given daily for two weeks. The active stimulation works by activating spinal roots and increasing brain activity related to movement. During the study, participants will be evaluated at the start, after two weeks of treatment, and again 30 days later. Researchers will assess functional mobility, independence, lower limb motor function, balance, spasticity, sensory function, and participants perceptions of any changes. The entire study participation lasts at least 30 days after treatment completion to monitor outcomes and safety.

Age: 18Years - 75YearsAll GendersPhase Not Applicable
3 locations
E

Actively Recruiting

This research aims to evaluate the effects of an educational program on people with asthma. The study focuses on understanding how education about asthma management can impact knowledge, clinical control, and lung function. It is a randomized controlled clinical trial involving participants from the Pulmonary Function Clinic of the Department of Physiotherapy at the Federal University of Paraba. Participants are divided into two groups a control group receiving standard clinic follow-up, and an experimental group receiving an educational intervention bundle based on the 2024 Global Initiative for Asthma GINA guidelines. The educational session is a single group meeting lasting about 60 minutes, covering asthma causes, inhaler use, triggers, self-management, environmental control, and the importance of a written treatment plan and regular medical check-ups. Participants in the experimental group also receive a booklet and a diary to track medication use and healthcare visits. Participants will be assessed at the start and again 12 weeks later. Evaluations include lung function tests spirometry, asthma knowledge, inhalation therapy control, clinical asthma control using the Asthma Control Test ACT and C-ACT questionnaires, the number of asthma attacks, medication usage, hospitalizations, and emergency room visits. The study aims to measure changes in clinical asthma control and knowledge retention, along with secondary outcomes like hospital visits and lung function, to understand the interventions impact over the study period.

Age: 8Years +All GendersPhase Not Applicable
1 location
L

Actively Recruiting

Researchers are evaluating the long-term safety of two drugs, Deucravacitinib and Ustekinumab, in adults with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic treatments. This study is designed to compare these treatments over an extended period, focusing on cardiovascular health and other safety outcomes. The study is sponsored by Bristol-Myers Squibb and is a Phase 3b4 randomized, open-label trial. Participants are randomly assigned to receive either Deucravacitinib or Ustekinumab at specified doses on scheduled days. The study spans up to 5 years, during which participants will be monitored closely for cardiovascular events and other safety outcomes. Treatment adherence and effects will be regularly assessed throughout this long-term safety study. During the study, participants will undergo various evaluations including monitoring for major cardiovascular events such as heart attacks and strokes, other cardiovascular complications, and laboratory assessments including liver function and lipid panels. Researchers will also track serious adverse events and overall mortality up to 60 days after the last dose. This comprehensive monitoring ensures participant safety and gathers essential data on the long-term effects of the treatments over the studys duration, which lasts until January 2031.

Age: 40Years +All GendersPhase 3
411 locations